For patients who have chronic lymphocytic leukemia (CLL), experiencing Richter transformation with central nervous system ...
The risk for central nervous system (CNS) involvement is small in cases of diffuse large B-cell lymphoma (DLBCL) because only about 5% of patients develop it. But certain high-risk patients are even ...
In our experience, patients' histories often note a neurologic prodrome years before PCNSL. These lingering illnesses, suggestive of multiple sclerosis or vitritis, might reflect polyclonal lymphoid ...
Primary central nervous system lymphoma (PCNSL) is an aggressive diffuse large B-cell lymphoma confined to the brain, spinal cord, leptomeninges and eyes. Its pathogenesis is complex, involving ...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous and aggressive form of non-Hodgkin lymphoma, with a standard treatment approach typically involving R-CHOP. Despite overall favourable ...
Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective ...
A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The ...
Winter, a lymphoma specialist serving her first year as VeloSano's medical director, secured a pilot grant to study a breakthrough treatment for central nervous system lymphoma, one of the most ...
Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease Primary CNS lymphoma (PCNSL) is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback